NZ336042A - Farnesyl transferase inhibitors - Google Patents
Farnesyl transferase inhibitorsInfo
- Publication number
- NZ336042A NZ336042A NZ336042A NZ33604297A NZ336042A NZ 336042 A NZ336042 A NZ 336042A NZ 336042 A NZ336042 A NZ 336042A NZ 33604297 A NZ33604297 A NZ 33604297A NZ 336042 A NZ336042 A NZ 336042A
- Authority
- NZ
- New Zealand
- Prior art keywords
- farnesyl transferase
- transferase inhibitors
- formula
- preparation
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/72—4,7-Endo-alkylene-iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Epoxy Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Farnesyl transferase inhibitors, particularly, benzoperhydroisoindole compounds of formula I in which the substituents are as described in the specification, and process for its preparation. Also disclosed are the intermediates important in the preparation of formula I. The compounds produced according to the process claims have been found to be useful for the inhibition of farnesyl transferase and in treating diseases related to cell proliferations, especially cancer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9616206A FR2757855B1 (en) | 1996-12-30 | 1996-12-30 | NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| PCT/FR1997/002407 WO1998029390A1 (en) | 1996-12-30 | 1997-12-23 | Farnesyl transferase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ336042A true NZ336042A (en) | 2000-12-22 |
Family
ID=9499293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ336042A NZ336042A (en) | 1996-12-30 | 1997-12-23 | Farnesyl transferase inhibitors |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP0948483B1 (en) |
| JP (1) | JP2001509147A (en) |
| KR (1) | KR20000062391A (en) |
| AR (1) | AR008950A1 (en) |
| AT (1) | ATE214367T1 (en) |
| AU (1) | AU741921B2 (en) |
| BR (1) | BR9714498A (en) |
| CA (1) | CA2275943A1 (en) |
| CO (1) | CO4920252A1 (en) |
| CZ (1) | CZ233599A3 (en) |
| DE (1) | DE69711081T2 (en) |
| DK (1) | DK0948483T3 (en) |
| DZ (1) | DZ2389A1 (en) |
| EA (1) | EA002114B1 (en) |
| ES (1) | ES2172033T3 (en) |
| FR (1) | FR2757855B1 (en) |
| HU (1) | HUP0001747A3 (en) |
| ID (1) | ID22922A (en) |
| IL (1) | IL130453A0 (en) |
| MA (1) | MA26460A1 (en) |
| NO (1) | NO993225L (en) |
| NZ (1) | NZ336042A (en) |
| PE (1) | PE28199A1 (en) |
| PL (1) | PL334345A1 (en) |
| PT (1) | PT948483E (en) |
| SK (1) | SK88399A3 (en) |
| TN (1) | TNSN97214A1 (en) |
| TR (1) | TR199901502T2 (en) |
| UY (1) | UY24832A1 (en) |
| WO (1) | WO1998029390A1 (en) |
| YU (1) | YU30299A (en) |
| ZA (1) | ZA9711734B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2787327B1 (en) * | 1998-12-21 | 2003-01-17 | Aventis Pharma Sa | COMPOSITIONS CONTAINING FARNESYL TRANSFERASE INHIBITORS |
| FR2796640A1 (en) * | 1999-07-22 | 2001-01-26 | Aventis Pharma Sa | New 3,9-ethano-2,3,3a,4,9,9a-hexahydro-1H-benzo (f) isoindole derivatives, are farnesyl transferase inhibitors useful for treating hyperproliferative disorders, e.g. psoriasis, restenosis or especially cancer |
| FR2796641B1 (en) * | 1999-07-22 | 2001-09-21 | Aventis Pharma Sa | NOVEL PROCESS FOR THE PREPARATION OF BENZOPERHYDROISOINDOLE COMPOUNDS |
| FR2845994B1 (en) * | 2002-10-18 | 2006-05-19 | Servier Lab | NOVEL SUBSTITUTED BENZO [E] [1,4] OXAZINO [3,2-G] ISOINDOLE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| JP2007538004A (en) * | 2004-03-18 | 2007-12-27 | ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド | How to treat synucleinopathy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3597863B2 (en) * | 1993-11-05 | 2004-12-08 | ワーナー−ランバート・コンパニー | Protein: substituted di- and tripeptide inhibitors of farnesyltransferase |
| FR2736641B1 (en) * | 1995-07-10 | 1997-08-22 | Rhone Poulenc Rorer Sa | NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
-
1996
- 1996-12-30 FR FR9616206A patent/FR2757855B1/en not_active Expired - Fee Related
-
1997
- 1997-12-03 PE PE1997001089A patent/PE28199A1/en not_active Application Discontinuation
- 1997-12-23 PL PL97334345A patent/PL334345A1/en unknown
- 1997-12-23 ID IDW990618A patent/ID22922A/id unknown
- 1997-12-23 IL IL13045397A patent/IL130453A0/en unknown
- 1997-12-23 KR KR1019997005966A patent/KR20000062391A/en not_active Application Discontinuation
- 1997-12-23 HU HU0001747A patent/HUP0001747A3/en unknown
- 1997-12-23 AU AU56694/98A patent/AU741921B2/en not_active Ceased
- 1997-12-23 AT AT97953000T patent/ATE214367T1/en not_active IP Right Cessation
- 1997-12-23 JP JP52968698A patent/JP2001509147A/en not_active Ceased
- 1997-12-23 DK DK97953000T patent/DK0948483T3/en active
- 1997-12-23 EA EA199900608A patent/EA002114B1/en not_active IP Right Cessation
- 1997-12-23 YU YU30299A patent/YU30299A/en unknown
- 1997-12-23 ES ES97953000T patent/ES2172033T3/en not_active Expired - Lifetime
- 1997-12-23 NZ NZ336042A patent/NZ336042A/en unknown
- 1997-12-23 TR TR1999/01502T patent/TR199901502T2/en unknown
- 1997-12-23 CZ CZ992335A patent/CZ233599A3/en unknown
- 1997-12-23 PT PT97953000T patent/PT948483E/en unknown
- 1997-12-23 DE DE69711081T patent/DE69711081T2/en not_active Expired - Fee Related
- 1997-12-23 EP EP97953000A patent/EP0948483B1/en not_active Expired - Lifetime
- 1997-12-23 CA CA002275943A patent/CA2275943A1/en not_active Abandoned
- 1997-12-23 WO PCT/FR1997/002407 patent/WO1998029390A1/en not_active Application Discontinuation
- 1997-12-23 SK SK883-99A patent/SK88399A3/en unknown
- 1997-12-23 BR BR9714498A patent/BR9714498A/en not_active IP Right Cessation
- 1997-12-26 TN TNTNSN97214A patent/TNSN97214A1/en unknown
- 1997-12-26 MA MA24915A patent/MA26460A1/en unknown
- 1997-12-27 DZ DZ970239A patent/DZ2389A1/en active
- 1997-12-29 CO CO97075391A patent/CO4920252A1/en unknown
- 1997-12-30 AR ARP970106263A patent/AR008950A1/en unknown
- 1997-12-30 UY UY24832A patent/UY24832A1/en not_active Application Discontinuation
- 1997-12-30 ZA ZA9711734A patent/ZA9711734B/en unknown
-
1999
- 1999-06-29 NO NO993225A patent/NO993225L/en not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001233726A1 (en) | Farnesyl protein transferase inhibitors for treating breast cancer | |
| GB9903762D0 (en) | Organic compounds | |
| MY119007A (en) | Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases. | |
| ES2130452T3 (en) | CYCLOBUTANE DERIVATIVES USED AS INHIBITORS OF SQUALENE-SYNTHESASE AND PROTEIN FARNESYL TRANSFERASE. | |
| MX9803851A (en) | Novel macrocyclic compounds as metalloprotease inhibitors. | |
| YU6602A (en) | Pyrimidine-2,4,6-trione metalloproteinase inhibitors | |
| BG104813A (en) | Substituted indolinones having an inhibiting effect on kinases and cycline/cdk complexes | |
| UA39166C2 (en) | derivatives of N-hydroxyurea AS inhibitors of lipoxygenase by mammals, method for the preparation thereof and method for inhibiting lipoxygenase by mammals | |
| TW200510380A (en) | Mitotic kinesin inhibitors | |
| AU6894800A (en) | Caspase inhibitors and uses thereof | |
| DE60021381D1 (en) | CHINONIC COMPOUNDS FOR THE TREATMENT OF DISEASES | |
| AU7878998A (en) | Meiosis regulating compounds | |
| AU3052799A (en) | Pharmaceutical compositions comprising erythropoietin for treatment of cancer | |
| CA2266759A1 (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
| PL332240A1 (en) | Tricyclic compounds useful in inhibiting g-proteinic function and in treating proliferative diseases | |
| MY143570A (en) | Compounds useful for inhibition of farnesyl protein transferase | |
| NZ336042A (en) | Farnesyl transferase inhibitors | |
| AU7385398A (en) | Novel macrocyclic compounds as metalloprotease inhibitors | |
| TR199901275T2 (en) | Compounds useful for inhibition of farnesyl protein transferase. | |
| DE69926078D1 (en) | Farnesyl-protein transferase inhibitoren | |
| MY133606A (en) | Farnesyl transferase inhibitors | |
| NZ335057A (en) | Pentaerythritol derivatives, their production and use and intermediates for their synthesis | |
| BR9713744A (en) | Farnesyl transferase protein cycloalkyke inhibitors | |
| MXPA02008014A (en) | Nitroacridine tumor inhibitor compositions. | |
| IL136225A0 (en) | Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) |